Aditxt rises on starting manufacturing process for psoriasis drug candidate

Aditxt

21/10/2022 14:51

** Shares of drug developer Aditxt Inc  ADTX.O  gain ~5% to
$3.22
    ** Co initiates manufacturing process for its experimental
drug ADI-100 to treat psoriasis  urn:newsml:reuters.com:*:nBwbw1hp3a
    ** Plans to start human trials for the drug during H2 2023
    ** Psoriasis is caused when immune system attacks skin
cells, triggering chronic production of itchy, inflamed, thick
scaly skin patches
    ** Including session moves, stock down 88% YTD
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))